CDH12 and urinary bladder cancer: For example, high‐resolution multi‐omics characterization of heterogeneity within colorectal tumors was achieved using spatial genomics Slide‐DNA‐seq analysis in combination with Slide‐seqV2 analysis, revealing distinct sets of genes associated with clone‐specific genetic aberrations, local tumor microenvironment, or with both.[50] In bladder cancer, spatial proteomics together with SRT was used to identify significant co‐localization between CDH12+ epithelial cells and immune cells, especially T cells.